1. 632. A Randomized, Placebo-Controlled, Double-Blind, Clinical Trial Evaluating Two Dose Regimens of Rifaximin (550mg daily or twice-daily) for Chemoprophylaxis Against Travelers' Diarrhea Among Deployed U.S. and U.K. Military Personnel (PREVENT TD). (31st December 2020) Authors: Gutierrez, Ramiro L; Burns, Daniel; Lalani, Tahaniyat; Bennett-Carter, Denise; Fraser, Jamie; Riddle, Mark; Connor, Patrick; Porter, Chad; Troth, Thomas; Ruck, Richard; Barton, Jerry; Tilley, Drake H; Kunz, Anjali; Fairchok, Mary; Yun, Heather; Alvarez, Bryan; Higgins, Robert; Mitra, Indrani; Ste... Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S376 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. An outbreak ofShigella boydiiserotype 20 in January 2015 amongst United Kingdom healthcare workers involved in the Ebola response in Sierra Leone. Issue 11 (November 2018) Authors: Todkill, Daniel; Pudney, Rachel; Terrell, Andrew; Tuck, Jerry; Hutley, Emma; Dallman, Timothy J.; Jenkins, Claire; Manuel, Rohini; Wade, Michael; Puleston, Richard; Hawker, Jeremy Journal: Journal of medical microbiology Issue: Volume 67:Issue 11(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗